Andrea Lowden
Neurology with Special Qualifications in Child Neurology · Irving, TXNPI 1417181298
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,364 of the $25,213 with a category attached, or 72.8%. 14 manufacturers reported payments, led by UCB, Inc. at 45.6% of the total. 2025 is the largest year on record at $18,890, more than ten times the $36 reported in 2019. Among neurology with special qualifications in child neurology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $303.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$12K
- Otter Pharmaceuticals, LLC$6K
- Biocodex, Inc.$5K
- Livanova USA, Inc.$2K
- Neuropace, Inc.$337
- Jazz Pharmaceuticals Inc.$212
- plus $492 from 8 others
Across 8 payments — averaging $65,191 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ultragenyx Pharmaceutical Inc.$522K
What the payments were for
- Consulting fees$18,36473%
- Travel & lodging$3,42414%
- Food & beverage$3,42414%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 28 | $11,503 |
| Otter Pharmaceuticals, LLC | 12 | $5,789 |
| Biocodex, Inc. | 9 | $4,677 |
| Livanova USA, Inc. | 12 | $2,204 |
| Neuropace, Inc. | 3 | $337 |
| Jazz Pharmaceuticals Inc. | 7 | $212 |
| SK Life Science, Inc. | 3 | $170 |
| Biomarin Pharmaceutical Inc. | 1 | $109 |
| Upsher-smith Laboratories LLC | 2 | $71 |
| Neurelis, Inc. | 2 | $53 |
| Acadia Pharmaceuticals Inc | 1 | $27 |
| Nobelpharma America, LLC | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Aucta Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fintepla$10,645
- SYMPAZAN$5,591
- DIACOMIT$4,413
- VNS Therapy$2,002
- RNS Neurostimulator Kit$285
- Brineura$109
How this compares
$25,213 in reported general payments places this provider in the 90th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Irving
- Alison DolceIrving$31K
- Roy EltermanDallas$5.9M
- Huda ZoghbiHouston$5.5M
- Diana CastroDenton$343K
- Shade MoodyHouston$194K
- Mary Kay KoenigHouston$171K
- Michael PerryFort Worth$162K
- Raphael SchiffmannDallas$88K
- Mauricio Delgado-AyalaDallas$75K
- Kaitlin BatleyDallas$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.